This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Tranter, R. Articles by Healy, D. Search for Related Content PubMed PubMed Citation Articles by Tranter, R. Articles by Healy, D. Social Bookmarking                         What's this?

Neuroleptic discontinuation syndromes

North Wales Department of Psychological Medicine, Hergest Unit, Bangor LL57 2PW, UK

David Healy

North Wales Department of Psychological Medicine, Hergest Unit, Bangor LL57 2PW, UK

The existence of discontinuation syndromes following treatment with neuroleptic (antipsychotic) drugs was first outlined in the mid-1960s but the effects of such syndromes have been neglected since then. We have pursued evidence for the existence and nature of discontinuation syndromes following neuroleptics through reports of difficulties following the use of dopamine blocking anti-emetics, the use of chlorpromazine to treat tuberculosis, the use of antidepressant-neuroleptic combinations in affective disorders, the occurrence of tardive syndromes and studies designed to establish the existence of discontinuation syndromes in schizophrenia. Combined these bodies of data point strongly to the existence of discontinuation syndromes after cessation of treatment with neuroleptics which may involve features other than motor dyskinesias. There is at present little evidence on the relative frequency of such syndromes or predisposing factors. The area needs research input to establish the nature of the syndromes that may result, their frequency, predisposing factors and best methods of treatment.

Key Words: discontinuation syndromes • drug dependence • pharmacologic stress syndromes • tardive dysthymia; withdrawal

Journal of Psychopharmacology, Vol. 12, No. 4, 401-406 (1998)
DOI: 10.1177/026988119801200412


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. J. Nutt Death and Dependence: Current Controversies over the Selective Serotonin Reuptake Inhibitors J Psychopharmacol, December 1, 2003; 17(4): 355 - 364. [Abstract] [PDF]

				A. J. Goudie What is the clinical significance of the discontinuation syndrome seen with clozapine? J Psychopharmacol, March 1, 2000; 14(2): 188 - 190. [PDF]

				P. Haddad, J. Hellewell, and A. Young Reply to A. J. Goudie -- What is the clinical significance of the discontinuation syndrome seen with clozapine? J Psychopharmacol, March 1, 2000; 14(2): 191 - 192. [PDF]